Cargando…

Telaprevir or boceprevir for hepatitis C treatment: a first survey on pharmacoutilization

Detalles Bibliográficos
Autores principales: Capuozzo, Maurizio, Ottaiano, Alessandro, Nava, Eduardo, Scotti, Valerio, Cascone, Stefania, Vercellone, Adriano, Cinque, Claudia, Iaffaioli, Rosario V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774983/
https://www.ncbi.nlm.nih.gov/pubmed/24062687
http://dx.doi.org/10.3389/fphar.2013.00114
_version_ 1782284555260002304
author Capuozzo, Maurizio
Ottaiano, Alessandro
Nava, Eduardo
Scotti, Valerio
Cascone, Stefania
Vercellone, Adriano
Cinque, Claudia
Iaffaioli, Rosario V.
author_facet Capuozzo, Maurizio
Ottaiano, Alessandro
Nava, Eduardo
Scotti, Valerio
Cascone, Stefania
Vercellone, Adriano
Cinque, Claudia
Iaffaioli, Rosario V.
author_sort Capuozzo, Maurizio
collection PubMed
description
format Online
Article
Text
id pubmed-3774983
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-37749832013-09-23 Telaprevir or boceprevir for hepatitis C treatment: a first survey on pharmacoutilization Capuozzo, Maurizio Ottaiano, Alessandro Nava, Eduardo Scotti, Valerio Cascone, Stefania Vercellone, Adriano Cinque, Claudia Iaffaioli, Rosario V. Front Pharmacol Pharmacology Frontiers Media S.A. 2013-09-17 /pmc/articles/PMC3774983/ /pubmed/24062687 http://dx.doi.org/10.3389/fphar.2013.00114 Text en Copyright © 2013 Capuozzo, Ottaiano, Nava, Scotti, Cascone, Vercellone, Cinque and Iaffaioli. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Capuozzo, Maurizio
Ottaiano, Alessandro
Nava, Eduardo
Scotti, Valerio
Cascone, Stefania
Vercellone, Adriano
Cinque, Claudia
Iaffaioli, Rosario V.
Telaprevir or boceprevir for hepatitis C treatment: a first survey on pharmacoutilization
title Telaprevir or boceprevir for hepatitis C treatment: a first survey on pharmacoutilization
title_full Telaprevir or boceprevir for hepatitis C treatment: a first survey on pharmacoutilization
title_fullStr Telaprevir or boceprevir for hepatitis C treatment: a first survey on pharmacoutilization
title_full_unstemmed Telaprevir or boceprevir for hepatitis C treatment: a first survey on pharmacoutilization
title_short Telaprevir or boceprevir for hepatitis C treatment: a first survey on pharmacoutilization
title_sort telaprevir or boceprevir for hepatitis c treatment: a first survey on pharmacoutilization
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774983/
https://www.ncbi.nlm.nih.gov/pubmed/24062687
http://dx.doi.org/10.3389/fphar.2013.00114
work_keys_str_mv AT capuozzomaurizio telaprevirorboceprevirforhepatitisctreatmentafirstsurveyonpharmacoutilization
AT ottaianoalessandro telaprevirorboceprevirforhepatitisctreatmentafirstsurveyonpharmacoutilization
AT navaeduardo telaprevirorboceprevirforhepatitisctreatmentafirstsurveyonpharmacoutilization
AT scottivalerio telaprevirorboceprevirforhepatitisctreatmentafirstsurveyonpharmacoutilization
AT casconestefania telaprevirorboceprevirforhepatitisctreatmentafirstsurveyonpharmacoutilization
AT vercelloneadriano telaprevirorboceprevirforhepatitisctreatmentafirstsurveyonpharmacoutilization
AT cinqueclaudia telaprevirorboceprevirforhepatitisctreatmentafirstsurveyonpharmacoutilization
AT iaffaiolirosariov telaprevirorboceprevirforhepatitisctreatmentafirstsurveyonpharmacoutilization